180 related articles for article (PubMed ID: 20370321)
1. Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases.
Guyot N; Bergsson G; Butler MW; Greene CM; Weldon S; Kessler E; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
Biol Chem; 2010 Jun; 391(6):705-16. PubMed ID: 20370321
[TBL] [Abstract][Full Text] [Related]
2. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
4. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
5. Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media.
Bellemare A; Vernoux N; Morisset D; Bourbonnais Y
Antimicrob Agents Chemother; 2008 Feb; 52(2):483-90. PubMed ID: 18025118
[TBL] [Abstract][Full Text] [Related]
6. Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.
Bellemare A; Vernoux N; Morin S; Gagné SM; Bourbonnais Y
BMC Microbiol; 2010 Oct; 10():253. PubMed ID: 20932308
[TBL] [Abstract][Full Text] [Related]
7. The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.
Baranger K; Zani ML; Chandenier J; Dallet-Choisy S; Moreau T
FEBS J; 2008 May; 275(9):2008-20. PubMed ID: 18341586
[TBL] [Abstract][Full Text] [Related]
8. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases.
Matsumoto K; Shams NB; Hanninen LA; Kenyon KR
Invest Ophthalmol Vis Sci; 1993 May; 34(6):1945-53. PubMed ID: 8491548
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
10. Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes.
Meyer-Hoffert U; Wichmann N; Schwichtenberg L; White PC; Wiedow O
Exp Dermatol; 2003 Aug; 12(4):418-25. PubMed ID: 12930298
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin.
Simard M; Hill LA; Underhill CM; Keller BO; Villanueva I; Hancock RE; Hammond GL
Endocrinology; 2014 Aug; 155(8):2900-8. PubMed ID: 24848868
[TBL] [Abstract][Full Text] [Related]
13. Elastinolytic and proteolytic enzymes.
Kessler E; Safrin M
Methods Mol Biol; 2014; 1149():135-69. PubMed ID: 24818903
[TBL] [Abstract][Full Text] [Related]
14. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin".
Nara K; Ito S; Ito T; Suzuki Y; Ghoneim MA; Tachibana S; Hirose S
J Biochem; 1994 Mar; 115(3):441-8. PubMed ID: 7914520
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of polymorphisms in the peptidase inhibitor 3 (elafin) gene and validation of their contribution to risk of acute respiratory distress syndrome.
Tejera P; O'Mahony DS; Owen CA; Wei Y; Wang Z; Gupta K; Su L; Villar J; Wurfel M; Christiani DC
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):262-72. PubMed ID: 24617927
[TBL] [Abstract][Full Text] [Related]
16. The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm.
Li Q; Zhou X; Nie X; Yang J
Respiration; 2010; 79(1):68-75. PubMed ID: 19420899
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions.
Marquart ME; Caballero AR; Chomnawang M; Thibodeaux BA; Twining SS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3761-8. PubMed ID: 16186360
[TBL] [Abstract][Full Text] [Related]
18. Elafin is specifically inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage.
Kantyka T; Latendorf T; Wiedow O; Bartels J; Gläser R; Dubin G; Schröder JM; Potempa J; Meyer-Hoffert U
Biol Chem; 2009 Dec; 390(12):1313-20. PubMed ID: 19747076
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous production of proteases from Brazilian clinical isolates of Pseudomonas aeruginosa.
Galdino ACM; Viganor L; Ziccardi M; Nunes APF; Dos Santos KRN; Branquinha MH; Santos ALS
Enferm Infecc Microbiol Clin; 2017 Dec; 35(10):630-637. PubMed ID: 27480954
[TBL] [Abstract][Full Text] [Related]
20. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens.
Simpson AJ; Maxwell AI; Govan JR; Haslett C; Sallenave JM
FEBS Lett; 1999 Jun; 452(3):309-13. PubMed ID: 10386612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
